{
  "trial_id": "NCT03018652",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adult patients with frequent exacerbations of COPD (clinically dominant COPD in the case of multiple co-morbidities eg. bronchiectasis, interstitial lung disease, congestive heart failure)",
      "label": "met"
    },
    {
      "criterion": "Confirmed diagnosis of COPD (bronchodilator FEV1/FVC ratio <0.7 on spirometry within previous 12 months)",
      "label": "met"
    },
    {
      "criterion": "Age >40 years",
      "label": "met"
    },
    {
      "criterion": ">10 pack year smoking history",
      "label": "unknown"
    },
    {
      "criterion": "Frequent COPD exacerbations in the previous 12 months before enrollment, defined by one or both of the following:",
      "label": "unknown"
    },
    {
      "criterion": "Treatment as an outpatient with antibiotics or prednisone (physician diagnosed COPD exacerbation) on 2 previous occasions OR",
      "label": "unknown"
    },
    {
      "criterion": "One hospitalization for COPD exacerbation (as defined by 2/3 of increased dyspnea, sputum volume, or sputum purulence in patients with known airflow limitation)",
      "label": "unknown"
    },
    {
      "criterion": "Expected to live > 12 months",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Known severe hypersensitivity to immunoglobulin or its components (anaphylaxis)",
      "label": "unknown"
    },
    {
      "criterion": "Active or metastatic malignancy (including chronic lymphocytic leukemia) excluding local skin cancers",
      "label": "not_met"
    },
    {
      "criterion": "History of hematopoietic stem cell transplant or solid organ transplant",
      "label": "unknown"
    },
    {
      "criterion": "Current treatment with a biological therapy for other conditions",
      "label": "unknown"
    },
    {
      "criterion": "Concomitant significant immunodeficiency or use of immunosuppressive treatment (other than for COPD)",
      "label": "not_met"
    },
    {
      "criterion": "Alpha-1 antitrypsin deficiency (based on enzyme level from bloodwork)",
      "label": "unknown"
    },
    {
      "criterion": "Significant proteinuria (dipstick proteinuria \u2265 3+ AND known urinary protein loss \u2265 2 g/day or nephrotic syndrome) and/or has a history of acute renal failure and/or severe renal impairment (creatinine more than 2.5 times the upper limit of normal and/or on dialysis)",
      "label": "not_met"
    },
    {
      "criterion": "IgA deficiency (IgA <0.1 g/L)",
      "label": "unknown"
    }
  ],
  "notes": "Patient has multifactorial chronic hypoxemia and dyspnea thought due to diastolic CHF, pulmonary hypertension thought secondary to a chronic ASD and COPD on 5L home oxygen. Pulmonary consult recommended an empiric, compassionate sildenafil trial due to severe dyspneic symptomology preventing outpatient living.",
  "_meta": {
    "topic_id": "16",
    "trial_id": "NCT03018652",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}